Projects Pharmaceuticals

Economic analysis of Salmeterol for listing on the PBS

Projects Pharmaceuticals

Economic analysis of Salmeterol for listing on the PBS

Projects Pharmaceuticals

Economic analysis of Salmeterol for listing on the PBS

 

AHA undertook a major cost effectiveness study on behalf of GlaxoSmithKline Australia, who were preparing a submission to the Pharmaceutical Benefits Advisory Committee for the listing of Salmeterol on the PBS. This study involved reviewing the clinical trial data and evaluating the indicated patient benefits from using this long-acting bronchodilator.

This project involved an international literature search to identify the efficacy of similar drugs and their associated pricing and volume sales in overseas markets, to inform pricing and marketing decisions in Australia.